Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/PHARMAESSENTIA-CORPORATIO-26902371/news/PharmaEssentia-Corporation-reicht-die-Registrierung-von-BESREMi-als-neues-Medikament-fur-PV-in-Mala-42747355/?utm_source=whatsapp&utm_medium=social&utm_campaign=share